Advanced Proteome Therapeutics Announces Anti-Cancer R&D Gathers Momentum

Stock Information for Advanced Proteome Therapeutics Corporati

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Advanced Proteome Therapeutics Corporati

Advanced Proteome Therapeutics to Proceed with Its Proposed Plan of Arrangement
IIROC Trading Resumption - APC
Advanced Proteome Therapeutics Announces Its Proposed Plan of Arrangement
IIROC Trading Halt - APC
Advanced Proteome Therapeutics Announces Closing of Non-Brokered Private Placement
Advanced Proteome Therapeutics Announces Appointment of Mr. Cory Brandolini to the Board of Directors
Advanced Proteome Therapeutics Manuscript Published in Bioconjugate Chemistry
Advanced Proteome Therapeutics Receives Issued Patent

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.